Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Zenalux Adds Pressure Sensing Capability to Zenascope™ SystemPressure reading function allows users to dial in target pressure via user interface…
Working with research partners at Duke University, Roswell Cancer Institute, and elsewhere, the Zenascope has proven to effectively measure significant endpoints in biological tissue, including: hemoglobin concentration, oxygen saturation, cell density and any other endpoints of interest that absorb white light. The company’s research partners are working on applications involving detection of cancer as well monitoring response to therapy. “Our collaborative work on biological tissue endpoint monitoring has conclusively demonstrated the need to maintain specific target pressure ranges in these measurements. For example, measurements on cancer tumors are pressure dependent,” explained Jesko von Windheim, CEO of Zenalux. “Eliminating variations in pressure ensures that our customers will get consistent measurement accuracy. This feature is one of several capability enhancements for the Zenascope as we further develop the system.” The Zenascope PC1, an ultraviolet- The specialized, real-time, diagnostic device shines white light on opaque target media and then measures and analyzes the reflected signal. The system achieves rapid, quantitative, and non-destructive analysis of the following biological endpoints: oxy-hemoglobin concentration ([HBO2]); deoxy-hemoglobin concentration ([HHb]); total hemoglobin concentration (THC); blood saturation (SO2); and scatterer size and density. Through its Research Partnership Program, Zenalux is working with a host of collaborators to add additional endpoints and develop numerous applications for the Zenascope™. Current applications under investigation for the Zenascope system include accelerating feedback in drug discovery; breast tumor margin assessment; assessment of response to cancer therapy; and screening and diagnostic applications in breast, cervical, and head and neck cancer. Zenascope is currently designated for investigational purposes only. Interested organizations can contact Zenalux at info@zenalux.com or 919-794-5757 x504. About Zenalux Biomedical, Inc. Zenalux Biomedical is a biomedical diagnostics start-up company that is developing novel biophotonic- End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|